Sylvère Brun
About Sylvère Brun
Sylvère Brun is the Associate Director of Global Regulatory Sciences Europe at Bristol Myers Squibb, with extensive experience in regulatory affairs across multiple companies and regions.
Current Position at Bristol Myers Squibb
Sylvère Brun is currently serving as the Associate Director for Global Regulatory Sciences Europe at Bristol Myers Squibb. Based in the London Area, United Kingdom, he applies his extensive expertise in regulatory operations to manage regulatory strategies and submissions for the region.
Previous Experience at Amgen
Before joining Bristol Myers Squibb, Sylvère Brun worked at Amgen. He held the position of Senior Manager Regulatory Affairs in Uxbridge, Greater London, from 2020 to 2021. Prior to that role, he served as Regulatory Affairs Manager from 2018 to 2020, also in Uxbridge. His responsibilities included overseeing regulatory submissions and ensuring compliance with local and international regulations.
Experience in Various Regulatory Roles
Sylvère Brun has held multiple roles across different companies in the regulatory affairs sector. He worked as an International Regulatory Affairs Associate for Septodont in 2017, focusing on the Asia and Pacific region. He also served in various capacities at STALLERGENES GREER, including Global Regulatory Affairs Associate and Regulatory Affairs Project Officer, and worked as a Regulatory Affairs Project Officer at Sanofi. His career started at Cyclopharma as a Regulatory Affairs Associate.
Educational Background
Sylvère Brun completed his studies at université d'auvergne (clermont - ferrand i) and université claude bernard lyon 1. He has a strong academic foundation that supports his extensive experience in regulatory affairs and quality assurance.
Specializations and Skills
Sylvère Brun specializes in expedited regulatory pathways for drug and medical device approvals. He has a profound understanding of drug lifecycle management, from early development phases to post-authorization studies. Additionally, he possesses significant experience in the geographical extension of drug registrations in emerging markets and is capable of working effectively in multi-disciplinary environments.